Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Normal levels of serum IGF-I: determinants and validity of current reference ranges.

Literature DB >> 17487588

Normal levels of serum IGF-I: determinants and validity of current reference ranges.

Abstract

Insulin like growth factor I (IGF-I) represents the key marker for the evaluation of Growth hormone (GH) status. As a large number of determinants including age, gender, genetic factors, nutrition, and disease states influence IGF-I serum levels, accurate normative data are essential to translate patient data into diagnostic meaning or even use IGF-I levels for adequate monitoring of patients with an over- or under-active GH axis. Even though reference ranges have been developed in large cohorts of healthy subjects, the dependency of these data on a given assay technology argues for assay specific normative data for IGF-I.

Entities: Chemical

Mesh：

Substances：

Year: 2007 PMID： 17487588 DOI： 10.1007/s11102-007-0035-9

Source DB: PubMed Journal: Pituitary ISSN： 1386-341X Impact factor: 3.599

39 in total

1. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction.

Authors: N Vaessen; P Heutink; J A Janssen; J C Witteman; L Testers; A Hofman; S W Lamberts; B A Oostra; H A Pols; C M van Duijn
Journal: Diabetes Date: 2001-03 Impact factor: 9.461

2. An exonic splicing enhancer in human IGF-I pre-mRNA mediates recognition of alternative exon 5 by the serine-arginine protein splicing factor-2/alternative splicing factor.

Authors: Philip J Smith; Emma L Spurrell; John Coakley; Charles J Hinds; Richard J M Ross; Adrian R Krainer; Shern L Chew
Journal: Endocrinology Date: 2002-01 Impact factor: 4.736

3. Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development.

Authors: Daniela Milani; John D Carmichael; Joan Welkowitz; Steven Ferris; Richard E Reitz; Ann Danoff; David L Kleinberg
Journal: J Clin Endocrinol Metab Date: 2004-05 Impact factor: 5.958

Review 4. The role of the IGF system in cancer growth and metastasis: overview and recent insights.

Authors: Amir Abbas Samani; Shoshana Yakar; Derek LeRoith; Pnina Brodt
Journal: Endocr Rev Date: 2006-08-24 Impact factor: 19.871

Review 5. Nutritional regulation of the insulin-like growth factors.

Authors: J P Thissen; J M Ketelslegers; L E Underwood
Journal: Endocr Rev Date: 1994-02 Impact factor: 19.871

6. Changes in subcutaneous and visceral fat mass during growth hormone replacement therapy in adult men.

Authors: H de Boer; G J Blok; B Voerman; P Derriks; E van der Veen
Journal: Int J Obes Relat Metab Disord Date: 1996-06

7. Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells.

Authors: G von Wichert; P M Jehle; A Hoeflich; S Koschnick; H Dralle; E Wolf; B Wiedenmann; B O Boehm; G Adler; T Seufferlein
Journal: Cancer Res Date: 2000-08-15 Impact factor: 12.701

Review 8. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.

Authors: Andrew G Renehan; Marcel Zwahlen; Christoph Minder; Sarah T O'Dwyer; Stephen M Shalet; Matthias Egger
Journal: Lancet Date: 2004-04-24 Impact factor: 79.321

9. Serum IGF-I and IGFBP-3 levels of Turkish children during childhood and adolescence: establishment of reference ranges with emphasis on puberty.

Authors: Abdullah Bereket; Serap Turan; Anjumanara Omar; Mustafa Berber; Ahmet Ozen; Cengiz Akbenlioglu; Goncagul Haklar
Journal: Horm Res Date: 2006-02-03

10. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study.

Authors: Anders Juul; Thomas Scheike; Michael Davidsen; Jesper Gyllenborg; Torben Jørgensen
Journal: Circulation Date: 2002-08-20 Impact factor: 29.690

21 in total

1. Bone density in post-pubertal adolescent survivors of childhood brain tumors.

Authors: Laurie E Cohen; Joshua H Gordon; Erica Y Popovsky; Nina N Sainath; Henry A Feldman; Mark W Kieran; Catherine M Gordon
Journal: Pediatr Blood Cancer Date: 2011-08-29 Impact factor: 3.167

Review 2. The effects of testosterone and insulin-like growth factor 1 on motor system form and function.

Authors: Kentaro Oki; Timothy D Law; Anne B Loucks; Brian C Clark
Journal: Exp Gerontol Date: 2015-02-11 Impact factor: 4.032

3. Reference ranges for an automated chemiluminescent assay for serum insulin-like growth factor I (IGF-I) in a large population of healthy adults from Buenos Aires.

Authors: M Guitelman; F Smithuis; N Garcia Basavilbaso; C Aranda; B Fabre; A Oneto
Journal: J Endocrinol Invest Date: 2015-03-05 Impact factor: 4.256

4. Chronic activity-based therapy does not improve body composition, insulin-like growth factor-I, adiponectin, or myostatin in persons with spinal cord injury.

Authors: Todd A Astorino; Eric T Harness; Kara A Witzke
Journal: J Spinal Cord Med Date: 2014-08-17 Impact factor: 1.985